Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWSLP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,708
Award facts
- Contract value 100% obligated
- $24,708.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors, with a firm fixed price contract value of $24,708.11 and a completion date of August 4, 2025. This non-set-aside competitive award was executed on August 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to federal healthcare systems, particularly the Department of Defense medical supply chain.
This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply an extensive range of brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical devices to support military healthcare programs worldwide. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism, positioning itself competitively for potential participation in DLA's upcoming Pharmaceutical Prime Vendor Global Program Generation V regional contracts.
Quick answers
Who was awarded contract SPE2DB25FWSLP?
SPE2DB25FWSLP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FWSLP worth?
The government has obligated $24,708 on SPE2DB25FWSLP.
Is contract SPE2DB25FWSLP an order under another contract?
Yes. SPE2DB25FWSLP is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSLP competed?
The extent of competition for SPE2DB25FWSLP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award